Ocular Therapeutix, Inc. Profile Avatar - Palmy Investing

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets R…

Biotechnology
US, Bedford [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Ocular Therapeutix, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Ocular Therapeutix, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Ocular Therapeutix, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of OCUL's Analysis
CIK: 1393434 CUSIP: 67576A100 ISIN: US67576A1007 LEI: - UEI: -
Secondary Listings
OCUL has no secondary listings inside our databases.